Remifentanil
Small molecule targets OPRM1 via activation
Regulatory milestones approvals, filings & regulatory actions · 3 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansions (2) | US (FDA) | ULTIVA | — | 1999-10-15 – 2004-03-08 | fda.gov ↗ |
| Approved | US (FDA) | ULTIVA | — | 1996-07-12 | fda.gov ↗ |
Trials 224 · started per year
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 02 trials · 1 missed | ||||||
| Phase 0 | NCT06312657 | Mar 2023 → Mar 2025 | substance-related disorder | University of Kentucky | Terminated | No outcome recorded Stop: Business |
| Phase 0 | NCT02898792 | Sep 2016 → May 2018 | sleep apnea syndrome | Washington University School of Medicine | Completed | Missed primary |
| Phase 15 trials | ||||||
| Phase 1 | NCT07603596 | May 2026 → Apr 2028 expected | delirium, digestive system neoplasm | Qianfoshan Hospital | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT04670471 | Apr 2021 → Jan 2022 | — | Paion UK Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT04301895 | Apr → Sep 2019 | acute opioid poisoning, respiratory underresponsiveness to hypoxia and hypercapnia | University of California, San Francisco | Completed | No outcome recorded |
| Phase 1 | NCT02473354 | Apr 2015 → Apr 2018 | respiratory underresponsiveness to hypoxia and hypercapnia | Duke University | Completed | No outcome recorded |
| Phase 1 | NCT02602002 | Apr → Jun 2008 | — | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 1/24 trials | ||||||
| Phase 1/2 | NCT03928366 | Jun 2017 → Jan 2019 | codeine toxicity | Parc de Salut Mar | Completed | No outcome recorded |
| Phase 1/2 | NCT01477892 | Dec 2011 → Apr 2012 | — | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 1/2 | NCT00213239 | Sep 2005 → Sep 2007 | hematologic disorder, neoplasm | The Hospital for Sick Children | Completed | No outcome recorded |
| Phase 1/2 | NCT00730054 | Feb → May 2005 | — | Oslo University Hospital | Completed | No outcome recorded |
| Phase 26 trials | ||||||
| Phase 2 | NCT04204967 | Feb 2021 → Apr 2024 | respiratory failure | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Completed | No outcome recorded |
| Phase 2 | NCT03443518 | Feb → Nov 2018 | — | Dr. Erfan and Bagedo General Hospital | Completed | No outcome recorded |
| Phase 2 | NCT02432677 | Jul 2014 → Dec 2015 | — | Hospital de Clinicas de Porto Alegre | Unknown | No outcome recorded |
| Phase 2 | NCT00522587 | Apr 2008 → Jul 2009 | — | University Hospital, Ghent | Completed | No outcome recorded |
| Phase 2 | NCT00693160 | Dec 2007 → Oct 2010 | — | Wake Forest University | Terminated | No outcome recorded |
| Phase 2 | NCT00315536 | May 2006 → Apr 2009 | — | University Hospital, Ghent | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT05391555 | Oct 2022 → Jun 2023 | abnormal pupillary function, poisoning, respiratory underresponsiveness to hypoxia and hypercapnia | University of California, San Francisco | Completed | No outcome recorded |
| Phase 320 trials · 1 met primary · 3 missed | ||||||
| Phase 3 | NCT05641909 | Aug 2021 → Dec 2022 | — | Southeast University, China | Unknown | No outcome recorded |
| Phase 3 | NCT05003570 | Jun 2021 → Dec 2022 | — | Southeast University, China | Unknown | No outcome recorded |
| Phase 3 | NCT03960801 | Oct 2019 → Apr 2021 | — | Nantes University Hospital | Completed | Missed primary |
| Phase 3 | NCT03618082 | Jun 2019 → May 2022 | — | University Hospital, Clermont-Ferrand | Unknown | No outcome recorded |
| Phase 3 | NCT03089905 | Aug 2017 → Oct 2026 expected | poisoning | Murdoch Childrens Research Institute | Active not recruiting | No outcome recorded |
| Phase 3 | NCT03065309 | Feb 2017 | hypotensive disorder | Brasilia University Hospital | Completed | No outcome recorded |
| Phase 3 | NCT02597699 | Dec 2015 → Mar 2019 | — | University Hospital, Montpellier | Completed | Missed primary |
| Phase 3 | NCT02481791 | Jul 2015 → Dec 2019 | heart disorder | Alder Hey Children's NHS Foundation Trust | Unknown | No outcome recorded |
| Phase 3 | NCT02033629 | May 2014 → May 2019 | cardiac valvular defect | Imam Abdulrahman Bin Faisal University | Completed | No outcome recorded |
| Phase 3 | NCT01998165 | Nov 2013 → Nov 2014 | — | Janssen Pharmaceutical K.K. | Completed | No outcome recorded |
| Phase 3 | NCT01735669 | Jul 2012 → Apr 2013 | neonatal compartment syndrome, pregnancy disorder | Hospital de Cruces | Completed | No outcome recorded |
| Phase 3 | NCT01102101 | Aug 2010 → Mar 2011 | postherpetic neuralgia | Medical University of Vienna | Unknown | No outcome recorded |
| Phase 3 | NCT01048398 | Jun 2010 → Apr 2011 | pregnancy disorder | Basque Health Service | Completed | No outcome recorded |
| Phase 3 | NCT02093143 | Jun 2009 → Feb 2013 | upper aerodigestive tract neoplasm | Centre Hospitalier Universitaire de Besancon | Completed | No outcome recorded |
| Phase 3 | NCT00741351 | Dec 2007 → Mar 2009 | — | Azienda Ospedaliera San Gerardo di Monza | Completed | No outcome recorded |
| Phase 3 | NCT00436345 | Nov 2007 → Aug 2008 | — | GlaxoSmithKline | Terminated | No outcome recorded Stop: Enrollment |
| Phase 3 | NCT00474071 | Mar 2007 → Apr 2008 | — | University of British Columbia | Completed | No outcome recorded |
| Phase 3 | NCT00405522 | Nov 2006 → Jun 2007 | — | The Hospital for Sick Children | Completed | No outcome recorded |
| Phase 3 | NCT00389883 | Nov 2006 → Jan 2010 | supratentorial cancer | Assistance Publique - Hôpitaux de Paris | Completed | Missed primary |
| Phase 3 | NCT00419601 | Nov 2006 → Apr 2010 | — | University of Cologne | Completed | Met primary |
| Phase 484 trials · 5 met primary · 2 missed | ||||||
| Phase 4 | NCT07857356 | Oct → Nov 2026 expected | — | Pamukkale University | Recruiting | No outcome recorded |
| Phase 4 | NCT07835295 | Sep 2026 → Sep 2028 expected | — | Mayo Clinic | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07334132 | Apr 2026 → Dec 2029 expected | osteoarthritis | Region Örebro County | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06564857 | Nov 2025 → Apr 2027 expected | — | Nordsjaellands Hospital | Recruiting | No outcome recorded |
| Phase 4 | NCT07105839 | Aug 2025 → Jan 2026 overdue | obesity disorder | Siirt Training and Research Hospital | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT01003028 | Nov 2024 → Dec 2025 overdue | — | Seoul National University Hospital | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06454292 | Jun 2024 → Dec 2025 | — | Chun Pan | Unknown | No outcome recorded |
| Phase 4 | NCT06331663 | Apr → Jun 2024 | — | Kaohsiung Medical University Chung-Ho Memorial Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT05876039 | May 2023 → Aug 2024 | — | Tri-Service General Hospital (TSGH) | Completed | No outcome recorded |
| Phase 4 | NCT05825560 | May 2023 → Jun 2026 | — | Nîmes University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT05125328 | Apr → Jun 2023 | — | Kaohsiung Medical University Chung-Ho Memorial Hospital | Completed | No outcome recorded |
| Phase 4 | NCT05706844 | Mar 2023 → Apr 2025 | osteoarthritis, hip, osteoarthritis, knee | Anders Troelsen | Completed | No outcome recorded |
| Phase 4 | NCT04073173 | Nov 2020 → Oct 2022 | respiratory distress syndrome in premature infants | Virgilio Paolo Carnielli | Unknown | No outcome recorded |
| Phase 4 | NCT03994146 | Jan 2020 → Aug 2023 | — | University Hospital, Akershus | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT05014711 | Jan 2020 → Dec 2021 | — | Capital Medical University | Unknown | No outcome recorded |
| Phase 4 | NCT04117009 | Nov 2019 → Jun 2020 | diastolic heart failure | Yeditepe University | Unknown | No outcome recorded |
| Phase 4 | NCT04026074 | Jul → Oct 2019 | arthropathy | Medical University of Graz | Completed | No outcome recorded |
| Phase 4 | NCT03783676 | Feb → Jun 2019 | — | University of Vermont Medical Center | Unknown | No outcome recorded |
| Phase 4 | NCT03901716 | Jan → Mar 2019 | — | Guangzhou Institute of Respiratory Disease | Completed | No outcome recorded |
| Phase 4 | NCT03812003 | Jan → Dec 2019 | substance-related disorder | Tri-Service General Hospital (TSGH) | Completed | No outcome recorded |
| Phase 4 | NCT03143972 | Jun 2017 → Feb 2018 | — | University Medical Center Groningen | Completed | No outcome recorded |
| Phase 4 | NCT02655380 | Jun 2017 → Apr 2018 | — | Ajou University School of Medicine | Completed | No outcome recorded |
| Phase 4 | NCT02733835 | Dec 2016 → Dec 2017 | — | KK Women's and Children's Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02602743 | Aug 2016 → Jan 2017 | — | Cukurova University | Completed | No outcome recorded |
| Phase 4 | NCT02999126 | Aug 2016 → Dec 2020 | — | Hospital Italiano de Buenos Aires | Unknown | No outcome recorded |
| Phase 4 | NCT02454868 | Jul 2016 | — | Brasilia University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02799589 | Jul 2016 → Aug 2017 | — | Mofya Diallo | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT02809378 | Jun 2016 → Apr 2017 | — | Ajou University School of Medicine | Completed | No outcome recorded |
| Phase 4 | NCT02717780 | Feb 2016 → Jun 2018 | obstructive sleep apnea syndrome | Centre Hospitalier Universitaire Vaudois | Completed | Missed primary |
| Phase 4 | NCT02349152 | Jan → Dec 2016 | heart disorder, hyperglycemia | Kathirvel Subramaniam | Completed | No outcome recorded |
| Phase 4 | NCT02635802 | Dec 2015 → Jun 2016 | — | The First Affiliated Hospital of Zhengzhou University | Unknown | No outcome recorded |
| Phase 4 | NCT02566733 | Oct 2015 → Jun 2016 | — | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02486328 | May → Jun 2015 | cognitive disorder, digestive system disorder | Ufuk University | Completed | Met primary |
| Phase 4 | NCT02353182 | May 2015 → Sep 2016 | — | Murdoch Childrens Research Institute | Completed | No outcome recorded |
| Phase 4 | NCT02382354 | Mar → Sep 2015 | — | Ajou University School of Medicine | Completed | No outcome recorded |
| Phase 4 | NCT02334046 | Feb → Nov 2015 | substance abuse | Ajou University School of Medicine | Completed | No outcome recorded |
| Phase 4 | NCT02593942 | Jan → Sep 2015 | supratentorial cancer | Yeditepe University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02379715 | Dec 2014 → May 2015 | — | Ajou University School of Medicine | Completed | No outcome recorded |
| Phase 4 | NCT02208778 | Dec 2014 → Jun 2016 | chronic pain syndrome, osteoarthritis | University of Nottingham | Completed | No outcome recorded |
| Phase 4 | NCT02528825 | Nov 2014 → Aug 2015 | — | Ajou University School of Medicine | Completed | No outcome recorded |
| Phase 4 | NCT02206022 | Aug 2014 → Dec 2017 | — | University Hospital, Toulouse | Completed | No outcome recorded |
| Phase 4 | NCT02078583 | Jul 2014 → Jun 2015 | delirium | Peking University People's Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02104297 | Apr → Jun 2014 | — | Diskapi Yildirim Beyazit Education and Research Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT03132519 | Oct 2013 → Nov 2015 | hypertensive disorder | Fundacion Clinica Valle del Lili | Completed | No outcome recorded |
| Phase 4 | NCT01931683 | Oct 2013 → Feb 2014 | substance abuse | Ajou University School of Medicine | Completed | No outcome recorded |
| Phase 4 | NCT01872754 | Jul 2013 → Apr 2017 | — | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| Phase 4 | NCT01910285 | Jun 2013 → Sep 2015 | — | University Hospital, Toulouse | Completed | No outcome recorded |
| Phase 4 | NCT01930747 | Apr 2013 → Dec 2015 | — | AZ Sint-Jan AV | Completed | No outcome recorded |
| Phase 4 | NCT02884310 | Jan 2013 → Dec 2014 | local anesthetic poisoning | Erasme University Hospital | Completed | Missed primary |
| Phase 4 | NCT01761149 | Dec 2012 → Mar 2013 | nodular goiter | Central South University | Unknown | Met primary |
| Phase 4 | NCT01693185 | Dec 2012 → Feb 2013 | — | Konkuk University Medical Center | Completed | Met primary |
| Phase 4 | NCT01702389 | Oct → Dec 2012 | — | Oslo University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01998217 | Sep 2012 → Dec 2013 | pancreas disorder | Changhai Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01634594 | Jun 2012 → Feb 2013 | autosomal dominant prognathism | Yonsei University | Completed | No outcome recorded |
| Phase 4 | NCT01628562 | Jun 2012 → Sep 2014 | cardiac rhythm disease, hypertensive disorder, myocardial ischemia | Diskapi Teaching and Research Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01833819 | Jun 2012 → Apr 2013 | cholecystitis | Bezmialem Vakif University | Completed | No outcome recorded |
| Phase 4 | NCT01974648 | May 2012 → Jun 2013 | — | Hospital General Universitario Gregorio Marañon | Completed | Met primary |
| Phase 4 | NCT02664922 | May 2012 → Sep 2013 | heart disorder | University of California, Los Angeles | Terminated | No outcome recorded |
| Phase 4 | NCT01419405 | Dec 2011 → Mar 2012 | — | Oslo University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01901575 | Jul 2011 → Apr 2013 | ventricular tachycardia | NYU Langone Health | Completed | No outcome recorded |
| Phase 4 | NCT01259648 | Mar 2011 → May 2014 | cardiac rhythm disease | Nîmes University Hospital | Completed | Met primary |
| Phase 4 | NCT01191645 | Oct → Nov 2010 | dyskinesia of esophagus | Region Örebro County | Completed | No outcome recorded |
| Phase 4 | NCT01139671 | Jun 2010 → Jul 2011 | — | University Hospital, Clermont-Ferrand | Completed | No outcome recorded |
| Phase 4 | NCT01714388 | May 2010 → Feb 2015 | — | Medical University of Gdansk | Completed | No outcome recorded |
| Phase 4 | NCT01291849 | Mar → May 2010 | — | Yonsei University | Completed | No outcome recorded |
| Phase 4 | NCT01052324 | Mar → Nov 2010 | cervical disk degenerative disorder, spinal stenosis | Yonsei University | Completed | No outcome recorded |
| Phase 4 | NCT01452880 | Jan → Jul 2010 | urolithiasis | University of Roma La Sapienza | Completed | No outcome recorded |
| Phase 4 | NCT01015482 | Nov 2009 → Mar 2010 | — | Medical University of Vienna | Unknown | No outcome recorded |
| Phase 4 | NCT01025245 | Nov 2009 → Jan 2010 | — | Yonsei University | Completed | No outcome recorded |
| Phase 4 | NCT01627873 | Aug 2009 → Jul 2011 | — | Catholic University of the Sacred Heart | Completed | No outcome recorded |
| Phase 4 | NCT00886106 | Jun → Dec 2009 | — | Medical University of Vienna | Unknown | No outcome recorded |
| Phase 4 | NCT01229527 | Apr 2009 → Dec 2010 | — | Ospedale San Raffaele | Completed | No outcome recorded |
| Phase 4 | NCT00811837 | Jan → Jul 2009 | — | Medical University of Vienna | Unknown | No outcome recorded |
| Phase 4 | NCT00789386 | Nov 2008 → Oct 2009 | — | Medical University of Vienna | Unknown | No outcome recorded |
| Phase 4 | NCT00778505 | Oct 2008 → Dec 2012 | — | Hopital Foch | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT00772616 | Sep 2008 → Jan 2010 | — | Hopital Foch | Completed | No outcome recorded |
| Phase 4 | NCT00710086 | Jul 2008 → Sep 2009 | — | Nanjing Medical University | Completed | No outcome recorded |
| Phase 4 | NCT00665119 | Apr → Oct 2008 | respiratory failure | Fondazione Poliambulanza Istituto Ospedaliero | Completed | No outcome recorded |
| Phase 4 | NCT00611195 | Jan 2008 → Oct 2012 | respiratory tract infectious disorder | Thomas Erb | Completed | No outcome recorded |
| Phase 4 | NCT00421720 | Jan 2007 → ? | — | GlaxoSmithKline | Terminated | No outcome recorded |
| Phase 4 | NCT00349245 | Jun 2006 → Aug 2007 | — | The University of Texas Health Science Center, Houston | Completed | No outcome recorded |
| Phase 4 | NCT00326859 | Aug 2005 → Sep 2006 | — | Montreal Burn Centre | Terminated | No outcome recorded |
| Phase 4 | NCT00158873 | Sep 2004 → ? | — | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 4 | NCT00391105 | Apr 2004 → Nov 2005 | respiratory distress syndrome in premature infants | Federal University of Minas Gerais | Completed | No outcome recorded |
| Phase not applicable102 trials · 5 met primary · 4 missed | ||||||
| — | NCT07695220 | Dec 2026 → Oct 2028 expected | intracerebral hemorrhage | The Third Affiliated Hospital of Southern Medical University | Not yet recruiting | No outcome recorded |
| — | NCT06727435 | Aug 2026 → Apr 2028 expected | — | Beijing Tiantan Hospital | Not yet recruiting | No outcome recorded |
| — | NCT07660861 | Jun 2026 → Jun 2027 expected | intracranial berry aneurysm, intracranial hypertension | Fatih Sultan Mehmet Training and Research Hospital | Not yet recruiting | No outcome recorded |
| — | NCT07462949 | Mar → Apr 2026 | — | Guangzhou General Hospital of Guangzhou Military Command | Completed | No outcome recorded |
| — | NCT07640243 | Feb → May 2026 overdue | cancer, cholangitis | Ankara City Hospital Bilkent | Recruiting | No outcome recorded |
| — | NCT07568405 | Jan → Jun 2026 overdue | — | Université Libre de Bruxelles | Enrolling by invitation | No outcome recorded |
| — | NCT07328958 | Jan → Dec 2026 expected | — | Sixth Affiliated Hospital, Sun Yat-sen University | Recruiting | No outcome recorded |
| — | NCT07325669 | Jan 2026 → Jan 2027 expected | — | dilara gocmen | Not yet recruiting | No outcome recorded |
| — | NCT07310524 | Sep → Nov 2025 | — | Muhammad Rahman Efendi Nasution | Completed | No outcome recorded |
| — | NCT07092384 | Jul → Nov 2025 | — | Tongji Hospital | Completed | No outcome recorded |
| — | NCT07002801 | Mar 2025 → Jun 2026 overdue | digestive system disorder | Harbin Medical University | Recruiting | No outcome recorded |
| — | NCT06658132 | Oct 2024 → Feb 2025 | Parkinson disease | RenJi Hospital | Completed | No outcome recorded |
| — | NCT06617039 | Oct 2024 → Jul 2025 overdue | — | Northern Jiangsu People's Hospital | Active not recruiting | No outcome recorded |
| — | NCT06531837 | Aug 2024 → Jan 2026 overdue | chronic pain syndrome | Beijing Tiantan Hospital | Not yet recruiting | No outcome recorded |
| — | NCT07094165 | Jul 2024 → Mar 2025 | acute kidney injury, crush syndrome, myopathy | Ankara City Hospital Bilkent | Completed | No outcome recorded |
| — | NCT06289829 | Apr 2024 → Mar 2026 | — | Yonsei University | Completed | No outcome recorded |
| — | NCT06237101 | Mar 2024 → Aug 2026 overdue | — | University of Chile | Recruiting | No outcome recorded |
| — | NCT06162390 | Nov 2023 → Mar 2024 | thyroid gland disorder | Kyungpook National University Chilgok Hospital | Completed | No outcome recorded |
| — | NCT05936671 | Jul 2023 → Jun 2025 overdue | — | Gangnam Severance Hospital | Recruiting | No outcome recorded |
| — | NCT05866315 | May → Sep 2023 | — | Wonkwang University Hospital | Completed | No outcome recorded |
| — | NCT05384665 | May → Oct 2023 | — | Centre Hospitalier Sud Francilien | Terminated | No outcome recorded |
| — | NCT05754762 | Mar → Jul 2023 | — | Yangzhou University | Unknown | No outcome recorded |
| — | NCT05279898 | Feb 2023 → Jun 2024 | delirium | Beth Israel Deaconess Medical Center | Completed | No outcome recorded |
| — | NCT07665645 | Jan → Jun 2023 | obesity disorder | Gaziantep City Hospital | Completed | No outcome recorded |
| — | NCT05551910 | Jan 2023 → Jan 2025 | — | The First Hospital of Jilin University | Unknown | Met primary |
| — | NCT03763305 | Jan → Dec 2023 | — | Seoul National University Hospital | Withdrawn | No outcome recorded |
| — | NCT05548465 | Sep 2022 → Oct 2023 | — | West China Hospital | Completed | No outcome recorded |
| — | NCT05242081 | Jul → Dec 2022 | substance-related disorder | The First Affiliated Hospital with Nanjing Medical University | Unknown | No outcome recorded |
| — | NCT05217238 | Dec 2021 → Mar 2022 | — | Yangzhou University | Unknown | No outcome recorded |
| — | NCT05004519 | Oct 2021 → Sep 2022 | — | Matthieu Clanet | Completed | Missed primary |
| — | NCT06033729 | Sep 2021 → Jul 2022 | lung cancer | Scarlata, Simone, M.D. | Completed | No outcome recorded |
| — | NCT05076903 | Sep 2021 → Nov 2022 | — | Gangnam Severance Hospital | Completed | No outcome recorded |
| — | NCT03417206 | Sep 2021 → Jan 2023 | — | Medical University of Silesia | Unknown | No outcome recorded |
| — | NCT04974060 | Jun → Dec 2021 | traumatic brain injury | Capital Medical University | Unknown | No outcome recorded |
| — | NCT04940273 | Jun → Dec 2021 | acquired aneurysmal subarachnoid hemorrhage | Capital Medical University | Unknown | No outcome recorded |
| — | NCT04734418 | Mar 2021 → Jan 2023 | — | Shanghai Zhongshan Hospital | Unknown | Met primary |
| — | NCT04553536 | Nov 2020 → Jun 2023 | poisoning | Second Hospital of Shanxi Medical University | Unknown | No outcome recorded |
| — | NCT04364945 | Jun 2020 → May 2028 expected | toxic encephalopathy | Seoul National University Hospital | Active not recruiting | No outcome recorded |
| — | NCT04236323 | Feb → Aug 2020 | neuropathy, painful | Seoul National University Hospital | Completed | No outcome recorded |
| — | NCT03868111 | Nov 2019 → Jan 2020 | — | Kangbuk Samsung Hospital | Completed | No outcome recorded |
| — | NCT03983889 | Jun → Nov 2019 | — | Changhai Hospital | Unknown | No outcome recorded |
| — | NCT03983915 | Jun → Nov 2019 | — | Changhai Hospital | Unknown | No outcome recorded |
| — | NCT04492813 | Dec 2018 → Jan 2021 | obesity disorder | University Hospital, Clermont-Ferrand | Completed | No outcome recorded |
| — | NCT03517735 | Dec 2018 → Mar 2019 | — | CMC Ambroise Paré | Terminated | Met primary |
| — | NCT03417180 | Sep 2018 → Jul 2023 | — | Medical University of Silesia | Unknown | No outcome recorded |
| — | NCT03622502 | Aug 2018 → Mar 2019 | — | Ajou University School of Medicine | Completed | No outcome recorded |
| — | NCT03817359 | Aug → Dec 2018 | — | Tri-Service General Hospital (TSGH) | Completed | No outcome recorded |
| — | NCT03540875 | Jul 2018 → Feb 2019 | — | CMC Ambroise Paré | Terminated | No outcome recorded |
| — | NCT03556696 | Jun 2018 → Jun 2022 | — | University Hospital, Lille | Completed | No outcome recorded |
| — | NCT03744949 | Mar → Oct 2018 | — | Ciusss de L'Est de l'Île de Montréal | Completed | No outcome recorded |
| — | NCT03406533 | Feb → Mar 2018 | — | Changhai Hospital | Terminated | No outcome recorded |
| — | NCT03406546 | Feb → Jun 2018 | — | Changhai Hospital | Terminated | No outcome recorded |
| — | NCT03207100 | Dec 2017 → Feb 2021 | — | Hong Yang | Completed | No outcome recorded |
| — | NCT03173339 | Jun → Aug 2017 | — | Keimyung University Dongsan Medical Center | Completed | No outcome recorded |
| — | NCT02973724 | Nov 2016 → Jun 2017 | substance abuse | Ajou University School of Medicine | Completed | No outcome recorded |
| — | NCT03389763 | Jun 2016 → Jan 2018 | — | Medical University of Silesia | Completed | No outcome recorded |
| — | NCT02683837 | Apr → Nov 2016 | — | University Hospital, Geneva | Withdrawn | No outcome recorded |
| — | NCT03508102 | Aug 2015 → Sep 2016 | — | West China Second University Hospital | Completed | No outcome recorded |
| — | NCT03037892 | Jun 2015 → May 2018 | — | King Hamad University Hospital, Bahrain | Completed | No outcome recorded |
| — | NCT02455401 | May 2015 → Nov 2017 | strabismus | Inje University | Completed | No outcome recorded |
| — | NCT02488486 | May 2015 → May 2017 | cardiac valvular defect | Hopital Foch | Terminated | No outcome recorded |
| — | NCT02405988 | Apr 2015 → Feb 2016 | — | Norwegian University of Science and Technology | Completed | No outcome recorded |
| — | NCT02429960 | Apr → Sep 2015 | — | University Medical Center Hamburg-Eppendorf | Completed | No outcome recorded |
| — | NCT02856087 | Nov 2014 → Apr 2015 | — | Seoul National University Hospital | Completed | Met primary |
| — | NCT02264626 | Oct 2014 → Oct 2017 | acute respiratory failure | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Unknown | No outcome recorded |
| — | NCT02245789 | Sep 2014 → Feb 2015 | — | Hopital Foch | Completed | Missed primary |
| — | NCT02108795 | Apr 2014 → Apr 2016 | delirium | Yeungnam University College of Medicine | Unknown | No outcome recorded |
| — | NCT02116868 | Mar 2014 → Mar 2018 | — | Central Hospital, Nancy, France | Completed | Met primary |
| — | NCT02001285 | Oct 2013 → Sep 2015 | — | Jeju National University School of Medicine | Unknown | No outcome recorded |
| — | NCT01919203 | Aug 2013 → Jul 2015 | respiratory system disorder | Sangjin Park | Completed | No outcome recorded |
| — | NCT02988050 | Aug 2013 → Feb 2016 | epilepsy | Menoufia University | Completed | No outcome recorded |
| — | NCT01912118 | Jul 2013 → Jun 2014 | — | Leiden University Medical Center | Completed | No outcome recorded |
| — | NCT01880931 | Jun 2013 → Nov 2014 | — | Severance Hospital | Completed | No outcome recorded |
| — | NCT01851005 | May 2013 → Feb 2014 | — | Chosun University Hospital | Completed | No outcome recorded |
| — | NCT01733472 | Jan 2013 → Feb 2014 | osteoarthritis | Region Skane | Completed | No outcome recorded |
| — | NCT02486926 | Nov 2012 → Jul 2013 | — | Hallym University Medical Center | Completed | No outcome recorded |
| — | NCT01735019 | Nov 2012 → Jul 2013 | — | Yonsei University | Completed | No outcome recorded |
| — | NCT01720498 | Oct 2012 → Jun 2013 | — | Severance Hospital | Completed | No outcome recorded |
| — | NCT02476981 | Aug 2012 → Jul 2014 | — | Hallym University Medical Center | Completed | No outcome recorded |
| — | NCT02430389 | Jul → Nov 2012 | — | Northwestern University | Terminated | Missed primary |
| — | NCT02001298 | Jun 2012 → Jul 2013 | hypotensive disorder | Jeju National University School of Medicine | Completed | No outcome recorded |
| — | NCT01303471 | Nov 2011 → Jan 2012 | — | University Hospital of Saint-Etienne | Completed | No outcome recorded |
| — | NCT01489137 | Nov 2011 → Feb 2012 | arteriovenous hemangioma/malformation, brain neoplasm | Seoul National University Hospital | Completed | No outcome recorded |
| — | NCT01614535 | Aug 2011 → Mar 2012 | — | Yonsei University | Completed | No outcome recorded |
| — | NCT01351285 | Apr → Oct 2011 | — | Yonsei University | Completed | No outcome recorded |
| — | NCT01550640 | Mar 2011 → Apr 2014 | pregnancy disorder | Charles University, Czech Republic | Completed | Missed primary |
| — | NCT02576600 | Oct 2010 → Dec 2012 | — | Pr Isabelle CONSTANT | Completed | No outcome recorded |
| — | NCT01147757 | Jun 2010 → Jun 2012 | — | Yonsei University | Unknown | No outcome recorded |
| — | NCT01026129 | Apr → Jun 2010 | — | University of Montreal Hospital Centre (CHUM) | Completed | No outcome recorded |
| — | NCT01082458 | Feb → Jul 2010 | — | Yonsei University | Completed | No outcome recorded |
| — | NCT01043952 | Jan 2010 → Mar 2012 | — | Aalborg University Hospital | Terminated | No outcome recorded Stop: Enrollment |
| — | NCT00926718 | Jun 2009 → Jun 2010 | laryngostenosis | St. Vincent's Medical Center | Unknown | No outcome recorded |
| — | NCT01604382 | Sep 2008 → May 2009 | osteoarthritis | Region Skane | Completed | No outcome recorded |
| — | NCT03378674 | Jan 2008 → Jul 2012 | — | Catholic University of the Sacred Heart | Completed | No outcome recorded |
| — | NCT00553553 | Sep 2007 → May 2008 | liver disorder | St Vincent's University Hospital, Ireland | Unknown | No outcome recorded |
| — | NCT00361686 | Jan 2006 → Jan 2007 | — | Rabin Medical Center | Completed | No outcome recorded |
| — | NCT01056224 | May 2005 → Jan 2010 | — | University Health Network, Toronto | Completed | No outcome recorded |
| — | NCT00162591 | Oct 2004 → ? | — | Assistance Publique - Hôpitaux de Paris | Unknown | No outcome recorded |
| — | NCT00615472 | Oct 2003 → Apr 2010 | Parkinson disease | Columbia University | Terminated | No outcome recorded Stop: Business |
| — | NCT00326352 | Jul 2003 → Jun 2005 | — | University of Edinburgh | Terminated | No outcome recorded |
| — | NCT00434382 | Oct 2002 → Dec 2003 | — | Ludwig-Maximilians - University of Munich | Unknown | No outcome recorded |
| — | NCT00588926 | — | movement disorder | Hadassah Medical Organization | Unknown | No outcome recorded |
| Comparator or background therapy341 trials | ||||||
| Phase 0 | NCT06810336 Comparator | Mar 2025 → Sep 2027 expected | brain injury, brain neoplasm | University of Virginia | Recruiting | No outcome recorded |
| Phase 0 | NCT06205719 Background | Jun 2024 → May 2025 | — | Sichuan Provincial People's Hospital | Unknown | No outcome recorded |
| Phase 0 | NCT06241131 Background | Mar → Dec 2024 | — | Sichuan Provincial People's Hospital | Unknown | No outcome recorded |
| Phase 0 | NCT05993039 Comparator | Sep 2023 → Dec 2024 | auditory system disorder | Our Lady of the Lake Hospital | Unknown | No outcome recorded |
| Phase 0 | NCT04016740 Background | Aug 2019 → Feb 2020 | coronary artery disorder, delirium | Beth Israel Deaconess Medical Center | Completed | No outcome recorded |
| Show all 341 trials opens the full record — a long page | ||||||
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2016-12-09 | Daiichi Sankyo | Daiichi Sankyo and Maruishi Pharmaceutical Launch Analgesic for General Anaesthesia Remifentanil Intravenous Injection 2mg and 5mg “Daiichi Sankyo” daiichisankyo.com ↗ |
Evidence & citations 23 cited values
Every value below carries the sentence it was read from. 569 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Remifentanil | “When participants reach the titration endpoint (OAAS score 1 point) during the titration of propofol in the induction, the investigators stop the dosing and switch to a...” NCT04595591 ↗551“The aim of this study was to investigate the pharmacodynamic profile of the innovative molecule of remifentanil (group O = Ultiva®) and two unbranded molecules (group A =...” NCT02048293 ↗ “Anesthesia was maintained with sevoflurane (Inhalation Sevoflurane, Brand: Kaiteli, Specification: 120 mL, Approval Number: National Drug Approval H20070172, Manufacturer:...” NCT07192549 ↗ “group BAL included patients who received balanced anesthesia with sevoflurane for 30 min before removal of the flap and throughout the surgery. The TCI group included patients...” PMID 27549313 ↗ Aug 2016 “Maintenance of anesthesia is with target-controlled infusion (Marsh and Minto algorithm) with propofol (Braun Medical, Germany) and remifentanil (GlaxoSmithKline, Great...” NCT01604382 ↗ “In the TIVA group (total intravenous anaesthesia group), induction and maintenance of anaesthesia will be performed using target-controlled infusion (TCI) with propofol...” NCT07325669 ↗ “Propofol and remifentanil will be infused during night-time (8 pm to 6:30 am) for ICU patients with mechanical ventilation or high-flow nasal cannula oxygen therapy (if...” NCT05718024 ↗ “Remifentanil will be administered by IV infusion and maintained at a dose of 0.025 μg/kg/min in non-mechanically ventilated patients and a dose of 0.05 μg/kg/min in...” NCT03207100 ↗ “Recently, remifentanil is commonly used short-acting opioid, and several studies have demonstrated the antitussive effect of remifentanil via effect-site target-controlled...” NCT01291849 ↗ “In the TIVA (Total Intra Venous Anesthesia) group, a combination of propofol (50-150 μg/kg/min) and remifentanil (0.02-0.2 μg/kg/min) was used for general anesthesia instead of...” NCT06558695 ↗ “Anesthesia induction was performed using propofol and remifentanil, followed by maintenance with sevoflurane to ensure adequate anesthetic depth and hemodynamic stability...” NCT07097220 ↗ |
| Known as | Fada Remifentanilo | “The aim of this study was to investigate the pharmacodynamic profile of the innovative molecule of remifentanil (group O = Ultiva®) and two unbranded molecules (group A =...” NCT02048293 ↗ |
| Known as | GI 87084B | ChEMBL registry synonym — accepted as the source's own label CHEMBL1005 ↗ |
| Known as | GI 87084X | ChEMBL registry synonym — accepted as the source's own label CHEMBL1005 ↗ |
| Known as | IDS-NR-005 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1005 ↗ |
| Known as | Ramifentanyl | ChEMBL registry synonym — accepted as the source's own label CHEMBL1005 ↗ |
| Known as | REM | “The aim of this study was to evaluate the efficacy of remifentanil (REM) versus dexmedetomidine (DEX) for treatment of cardiac surgery (CS) patients with moderate to severe NIV...” PMID 33209418 ↗ Oct 2020 |
| Known as | remi | “Dexmedetomidine/remifentanil (dex/remi group) and midazolam/remifentanil (mida/remi group) were infused 7 days apart.” PMID 17056949 ↗ Nov 2006 |
| Known as | Remifentanil ALVOGEN | “Remifentanil ALVOGEN®” NCT06640738 ↗ |
| Known as | remifentanil HCl | “Intra-operative intravenous remifentanil HCl at titratable dose range 0.1-0.25 micrograms/kilogram/minute until start of wound closure” NCT00553553 ↗ |
| Known as | Remifentanil Hydrochloride | “Morphine hydrochloride, remifentanil hydrochloride” NCT00553553 ↗6“Remifentanil Hydrochloride for Injection” NCT07372924 ↗ “Drug: Remifentanil Hydrochloride” NCT04409964 ↗ “Drug: Remifentanil Hydrochloride” NCT05391555 ↗ “Drug: Remifentanil Hydrochloride” NCT02967029 ↗ “Drug: Remifentanil Hydrochloride” NCT04906889 ↗ |
| Known as | remifentanil hydrochloride (JNJ-268229) | “remifentanil hydrochloride (JNJ-268229)” NCT01998165 ↗ |
| Known as | remifentanil hydrochloride for injection | “remifentanil hydrochloride for injection” NCT04974060 ↗ |
| Known as | Remifentanil Laboratorios Chalver de Colombia S.A. | “The aim of this study was to investigate the pharmacodynamic profile of the innovative molecule of remifentanil (group O = Ultiva®) and two unbranded molecules (group A =...” NCT02048293 ↗ |
| Known as | Remifentanil: Ultiva | “remifentanil (ultiva)” NCT02108795 ↗3“remifentanil (ultiva)” NCT01915108 ↗ “remifentanil (ultiva)” NCT01919203 ↗ “Remifentanil: Ultiva” NCT00627081 ↗ |
| Known as | Remifentanilo | ChEMBL registry synonym — accepted as the source's own label CHEMBL1005 ↗ |
| Known as | remifentanyl | “Compare the opioid based anesthesia with Fentanyl and Remifentanyl to opioid free anesthesia with dexmedetomidine and lidocaine and their effect on postoperative pain.” NCT03417193 ↗ |
| Known as | Ultiva | “Remifentanil (Ultiva®; Glaxo-Smith-Kline; Vienna, Austria) will be applied intravenously during 60 minutes through a dedicated infusion pump (TCI Alaris PK Syringe Pump,...” NCT00886106 ↗14“Remifentanil (Ultiva; Glaxo-Smith-Kline; Vienna, Austria) will be applied intravenously during 60 minutes through a dedicated infusion pump (TCI Alaris PK Syringe Pump,...” NCT01102101 ↗ “The aim of this study was to investigate the pharmacodynamic profile of the innovative molecule of remifentanil (group O = Ultiva®) and two unbranded molecules (group A =...” NCT02048293 ↗ “Remifentanil (Ultiva, Glaxo SmithKline, Turkey) infusion was started at a dose of 0.05 µg/kg/min-1, 10 minutes before the start of the surgery as baseline infusion and...” NCT04935541 ↗ “Remifentanil (Ultiva), a 4-anilidopiperidine derivative of fentanyl, is an ultra-short-acting micro-opioid receptor agonist indicated to provide analgesia and sedation in...” PMID 16526829 ↗ 2006 “For patients randomized to arm 2, we will inject 30 μg of intravenous Remifentanil (Ultiva®) followed by Xylocaine 1% in a 10 ml bolus (10 mg / ml).” NCT02597699 ↗ “Remifentanil (Ultiva ®; Glaxo-Smith-Kline; Vienna, Austria) at an initial dose of 0.24 µg kg-1 min-1 will be applied iv during 60 minutes.” NCT00789386 ↗ “Four measurements will be obtained at different target plasma concentrations of remifentanil(Ultiva®): 0, 1, 2, and 3 ng/mL.” NCT07568405 ↗ “Drug: Remifentanil (Ultiva). Intraoperative intravenous infusion of remifentanil 0.5-1 μg/kg/min for up to 1 h.” NCT02619032 ↗ “Maintenance will be achieved using remifentanil (Ultiva®) infusion at 0.1-0.3 µg/kg/min and 1 MAC sevoflurane.” NCT07105839 ↗ “High dose remifentanil (Ultiva,Glaxosmithkline, UK)” NCT02455401 ↗ |
| Known as | Ultiva (remifentanil) | “Ultiva (remifentanil)” NCT01375348 ↗ |
| Action | Activate | “Remifentanil is a μ-opioid receptor agonist” NCT00567957 ↗1“Mu opioid receptor agonist” CHEMBL1005 ↗ |
| Modality | Small molecule | “Remifentanil is an amidopiperidine derivative with unique pharmacokinetic properties.” NCT00335972 ↗ |
| Route | Other | “intravenius use” NCT00315536 ↗ |
| Target | OPRM1 | “Mu opioid receptor agonist” CHEMBL1005 ↗ |